Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
Sponsor: Epizyme, Inc.
Relapsed/Refractory Follicular Lymphoma · Follicular Lymphoma · Refractory Follicular Lymphoma
United States, Australia, Belgium, Brazil, Canada +12 more
- AI Screening for Diabetic RetinopathyRecruiting
Sponsor: West German Center of Diabetes and Health
Diabetes Mellitus
Germany
Sponsor: Alumis Inc
Plaque Psoriasis
United States, Austria, Canada, Estonia, France +7 more
- An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Active Not Recruiting
Sponsor: AstraZeneca
Breast Cancer, Early Breast Cancer
United States, Argentina, Australia, Austria, Belgium +39 more
Sponsor: CatalYm GmbH
Metastatic Non-Squamous Non-Small Cell Lung Cancer · Adult Solid Tumor
United States, Germany, Italy, Poland, Romania +2 more
- A Trial of Setmelanotide in Acquired Hypothalamic ObesityActive Not Recruiting
Sponsor: Rhythm Pharmaceuticals, Inc.
Hypothalamic Obesity
United States, Canada, Germany, Japan, Netherlands +1 more
Sponsor: Astellas Pharma Europe Ltd.
Hot Flashes
Germany
Sponsor: Biosense Webster, Inc.
Arrhythmias, Cardiac
Austria, Belgium, France, Germany, Switzerland
- Study of ALXN2220 Versus Placebo in Adults With ATTR-CMActive Not Recruiting
Sponsor: Alexion Pharmaceuticals, Inc.
Transthyretin Amyloid Cardiomyopathy
United States, Argentina, Australia, Austria, Belgium +22 more
- Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDActive Not Recruiting
Sponsor: COMPASS Pathways
Treatment Resistant Depression
United States, Canada, Czechia, Denmark, France +7 more
- A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic DermatitisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Atopic Dermatitis
United States, Brazil, Canada, France, Germany +3 more
- GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's DiseaseActive Not Recruiting
Sponsor: Hoffmann-La Roche
Huntington Disease
United States, Argentina, Australia, Austria, Canada +10 more
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Loneliness · Mental Well-being · Health-related Quality of Life
Germany
- A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmsActive Not Recruiting
Sponsor: Incyte Corporation
Myeloproliferative Neoplasms
Australia, Canada, Denmark, France, Germany +4 more
Sponsor: Avalyn Pharma Inc.
Idiopathic Pulmonary Fibrosis (IPF)
Australia, Canada, Germany, New Zealand, Spain +1 more
- OLE Study With Filgotinib in JIARecruiting
Sponsor: Alfasigma S.p.A.
Juvenile Idiopathic Arthritis (JIA)
France, Germany, United Kingdom
Sponsor: Novartis Pharmaceuticals
Immunoglobulin A Nephropathy (IgAN)
United States, Brazil, China, Czechia, Germany +6 more
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated RegimenActive Not Recruiting
Sponsor: Gilead Sciences
HIV-1-infection
United States, Argentina, Australia, Canada, Dominican Republic +10 more
Sponsor: CUTISS AG
Burns
Belgium, France, Germany, Italy, Netherlands +4 more
- A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkActive Not Recruiting
Sponsor: Sanofi
Chronic Inflammatory Demyelinating Polyradiculoneuropathy · Polyneuropathy, Inflammatory Demyelinating, Chronic
United States, Argentina, Belgium, Brazil, Bulgaria +19 more
Sponsor: Merck Sharp & Dohme LLC
Psoriatic Arthritis
United States, Canada, Chile, Colombia, Germany +3 more
Sponsor: Sanofi
Alopecia Areata
United States, Argentina, Australia, Bulgaria, Canada +11 more
- An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care TreatmentActive Not Recruiting
Sponsor: Hoffmann-La Roche
Von Willebrand Disease, Type 3
United States, Belgium, Canada, Colombia, France +9 more
Sponsor: AstraZeneca
ER-Positive HER2-Negative Breast Cancer
United States, France, Germany, Italy, Poland +4 more
Sponsor: Regeneron Pharmaceuticals
Follicular Lymphoma (FL)
United States, Australia, Austria, Belgium, Brazil +14 more